BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 12474413)

  • 1. [Economic prerequisites of active influenza prevention].
    Grześk G; Gałaj A; Korbal P; Durmowicz A; Szadujkis-Szadurski L; Borys D; Grześk E
    Med Pr; 2002; 53(4):329-32. PubMed ID: 12474413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishing the health and economic impact of influenza vaccination within the European Union 25 countries.
    Ryan J; Zoellner Y; Gradl B; Palache B; Medema J
    Vaccine; 2006 Nov; 24(47-48):6812-22. PubMed ID: 17034909
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effectiveness of vaccination against influenza in healthy, working adults.
    Nichol KL; Lind A; Margolis KL; Murdoch M; McFadden R; Hauge M; Magnan S; Drake M
    N Engl J Med; 1995 Oct; 333(14):889-93. PubMed ID: 7666874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral drugs in influenza: an adjunct to vaccination in some situations.
    Prescrire Int; 2006 Feb; 15(81):21-30. PubMed ID: 16548114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cost-effectiveness of prophylaxis and treatment of influenza].
    Rychlik R; Heinen-Kammerer T; Rusche H; Piercy J; Scuffham P; Zöllner Y
    Dtsch Med Wochenschr; 2003 Oct; 128(43):2267-70. PubMed ID: 14574642
    [No Abstract]   [Full Text] [Related]  

  • 6. [Health economic impact of viral respiratory infections and pneumonia diseases on the elderly population in Poland].
    Jahnz-Rózyk K
    Pol Merkur Lekarski; 2010 Jul; 29(169):37-40. PubMed ID: 20712246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and economic impact of influenza vaccination on healthy children aged 2-5 years.
    Esposito S; Marchisio P; Bosis S; Lambertini L; Claut L; Faelli N; Bianchi C; Colombo GL; Principi N
    Vaccine; 2006 Jan; 24(5):629-35. PubMed ID: 16157429
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influenza infection and vaccination in pregnant women.
    Tamma PD; Steinhoff MC; Omer SB
    Expert Rev Respir Med; 2010 Jun; 4(3):321-8. PubMed ID: 20524915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pharmaco-economics of anti-influenza vaccinations].
    Jahnz-Rózyk K
    Pol Merkur Lekarski; 2003 Jun; 14(84):679-81. PubMed ID: 14524303
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of live attenuated influenza vaccine versus inactivated influenza vaccine among children aged 24-59 months in the United States.
    Luce BR; Nichol KL; Belshe RB; Frick KD; Li SX; Boscoe A; Rousculp MD; Mahadevia PJ
    Vaccine; 2008 Jun; 26(23):2841-8. PubMed ID: 18462851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Maritime health: a case for preventing influenza on the high seas.
    Ruben FL; Ehreth J
    Int Marit Health; 2002; 53(1-4):36-42. PubMed ID: 12608587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming the challenges of immunosenescence in the prevention of acute respiratory illness in older people.
    McElhaney JE
    Conn Med; 2003 Sep; 67(8):469-74. PubMed ID: 14587126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Population-wide benefits of routine vaccination of children against influenza.
    Weycker D; Edelsberg J; Halloran ME; Longini IM; Nizam A; Ciuryla V; Oster G
    Vaccine; 2005 Jan; 23(10):1284-93. PubMed ID: 15652671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Socioeconomic impact of influenza on healthy children and their families.
    Principi N; Esposito S; Marchisio P; Gasparini R; Crovari P
    Pediatr Infect Dis J; 2003 Oct; 22(10 Suppl):S207-10. PubMed ID: 14551476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of clinical case definitions with differing levels of sensitivity and specificity on estimates of the relative and absolute health benefits of influenza vaccination among healthy working adults and implications for economic analyses.
    Nichol KL; Mendelman P
    Virus Res; 2004 Jul; 103(1-2):3-8. PubMed ID: 15163481
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccination versus treatment of influenza in working adults: a cost-effectiveness analysis.
    Rothberg MB; Rose DN
    Am J Med; 2005 Jan; 118(1):68-77. PubMed ID: 15639212
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-influenza vaccination for active persons (25-64 years): a cost-benefit study].
    Levy E; Levy P
    Rev Epidemiol Sante Publique; 1992; 40(5):285-95. PubMed ID: 1480805
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Risk of influenza in healthy children--vaccination benefits].
    Brydak LB
    Przegl Epidemiol; 2004; 58 Suppl 1():28-38. PubMed ID: 15807155
    [No Abstract]   [Full Text] [Related]  

  • 19. The economic implications of influenza vaccination for adults with asthma.
    Trogdon JG; Nurmagambetov TA; Thompson HF
    Am J Prev Med; 2010 Nov; 39(5):403-10. PubMed ID: 20965377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulating effect of influenza vaccination in the elderly differing in health status.
    Myśliwska J; Trzonkowski P; Szmit E; Brydak LB; Machała M; Myśliwski A
    Exp Gerontol; 2004 Oct; 39(10):1447-58. PubMed ID: 15501014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.